FI896062A0 - Granulat foer kompositioner med kontrollerad frigivning av laekemedel. - Google Patents

Granulat foer kompositioner med kontrollerad frigivning av laekemedel.

Info

Publication number
FI896062A0
FI896062A0 FI896062A FI896062A FI896062A0 FI 896062 A0 FI896062 A0 FI 896062A0 FI 896062 A FI896062 A FI 896062A FI 896062 A FI896062 A FI 896062A FI 896062 A0 FI896062 A0 FI 896062A0
Authority
FI
Finland
Prior art keywords
granulat
ceilings
frequency
composition
control
Prior art date
Application number
FI896062A
Other languages
English (en)
Inventor
Jan Willem Groenendaal
Edoaldus Vork
Ronde Hendrikus Adrianus Ge De
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of FI896062A0 publication Critical patent/FI896062A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI896062A 1988-12-20 1989-12-18 Granulat foer kompositioner med kontrollerad frigivning av laekemedel. FI896062A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88202983 1988-12-20

Publications (1)

Publication Number Publication Date
FI896062A0 true FI896062A0 (fi) 1989-12-18

Family

ID=8199893

Family Applications (1)

Application Number Title Priority Date Filing Date
FI896062A FI896062A0 (fi) 1988-12-20 1989-12-18 Granulat foer kompositioner med kontrollerad frigivning av laekemedel.

Country Status (16)

Country Link
EP (1) EP0375063B1 (fi)
JP (1) JPH02223513A (fi)
KR (1) KR900009059A (fi)
CN (1) CN1044398A (fi)
AU (1) AU622745B2 (fi)
CA (1) CA2005992A1 (fi)
DE (1) DE68909023T2 (fi)
DK (1) DK647689A (fi)
ES (1) ES2059710T3 (fi)
FI (1) FI896062A0 (fi)
HU (1) HU203279B (fi)
IL (1) IL92343A0 (fi)
NO (1) NO176125C (fi)
NZ (1) NZ231828A (fi)
PT (1) PT92616B (fi)
ZA (1) ZA899732B (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776493A (en) * 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
GB2253346A (en) * 1991-02-22 1992-09-09 John Rhodes Delayed release oral dosage forms for treatment of intestinal disorders
TW212139B (fi) * 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
ATE159426T1 (de) * 1991-04-16 1997-11-15 Nippon Shinyaku Co Ltd Verfahren zur herstellung einer festen dispersion
US5248310A (en) * 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5512299A (en) * 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
WO1995016451A1 (fr) * 1992-06-22 1995-06-22 Franck Arno Gouchet Comprimes a liberation controlee de 4-asa
FR2692484B1 (fr) * 1992-06-22 1995-06-30 Gouchet Franck Nouvelle forme galenique de 4-asa a liberation controlee.
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
AT403988B (de) * 1994-05-18 1998-07-27 Lannacher Heilmittel Festes orales retardpräparat
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
RU2246293C2 (ru) 1999-06-14 2005-02-20 Космо С.П.А. Фармацевтические композиции для перорального введения с регулируемым высвобождением активного ингредиента и маскируемым вкусом
ITMI991316A1 (it) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
JP4310605B2 (ja) * 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8557291B2 (en) 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US20130203721A1 (en) * 2010-02-22 2013-08-08 Lupin Limited Taste-masked powder for suspension compositions of methylprednisolone
IT1405012B1 (it) * 2010-08-06 2013-12-16 Sofar Spa Composizioni di beclometasone dipropionato in microsfere gastroresistenti a rilascio modificato e processo per il loro ottenimento
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations

Also Published As

Publication number Publication date
HUT53514A (en) 1990-11-28
EP0375063B1 (en) 1993-09-08
AU4713189A (en) 1990-06-28
DE68909023T2 (de) 1994-02-03
ZA899732B (en) 1990-09-26
JPH02223513A (ja) 1990-09-05
AU622745B2 (en) 1992-04-16
IL92343A0 (en) 1990-07-26
HU203279B (en) 1991-07-29
EP0375063A1 (en) 1990-06-27
PT92616B (pt) 1995-09-12
CN1044398A (zh) 1990-08-08
NO895114D0 (no) 1989-12-19
CA2005992A1 (en) 1990-06-20
NO176125B (no) 1994-10-31
DK647689D0 (da) 1989-12-19
NZ231828A (en) 1992-03-26
NO895114L (no) 1990-06-21
PT92616A (pt) 1990-06-29
DK647689A (da) 1990-06-21
NO176125C (no) 1995-02-08
KR900009059A (ko) 1990-07-02
HU896686D0 (en) 1990-02-28
ES2059710T3 (es) 1994-11-16
DE68909023D1 (de) 1993-10-14

Similar Documents

Publication Publication Date Title
FI896062A0 (fi) Granulat foer kompositioner med kontrollerad frigivning av laekemedel.
FI864700A0 (fi) Reglering av vridmomentet hos vindturbin med foeraenderlig hastighet.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
FI852516L (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
FI870919A0 (fi) Anordning foer avsaltning av saltvatten med membrandestillation.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO894210D0 (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO890483D0 (no) Framgangsmaate for tilvirkning av formlegemer.
NO892204L (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO862942D0 (no) Fremgangsmaate for fremstilling av kalsiumfluorsilikat.
NO890159L (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO861858L (no) Fremgangsmaate for fremstilling av vinylharpikser med hoey bulktetthet.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO169441C (no) Fremgangsmaate til fremstilling av 7-oksomitosanderivater
NO895040L (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
FI860911A (fi) Anordning foer reglering av roekgasernas utloppshastighet i en skorsten.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
FI843741A (fi) Anordning foer reglering av glappet i en kuggvaexel.
NO890819D0 (no) Fremgangsmaate for fremstilling av hydroksybenzaldehyder.
FI832056A0 (fi) Foerfarande foer baerighetsmaetning av vaeg- och gatukonstruktioner
NO903304L (no) Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: YAMANOUCHI EUROPE B.V.

FD Application lapsed
MM Patent lapsed

Owner name: YAMANOUCHI EUROPE B.V.